×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Exosome-Based Drug Delivery for CBS/PSP
therapeutic
3,343 words
KG: ent-dise-bfd8f32d
2026-03-24
kind:therapeutic
section:therapeutics
state:published
therapeutic-modality:exosome-delivery
disease:cbs
disease:psp
Contents
Exosome-Based Drug Delivery for CBS/PSP
💊
Therapeutic Info
Name
Exosome-Based Drug Delivery for CBS/PSP
Summary
Exosome-mediated therapeutic delivery for corticobasal syndrome and progressive supranuclear palsy - targeting methods, cargo loading, delivery routes, and clinical applications
Knowledge Graph
Related Hypotheses (30)
LRP1-Dependent Tau Uptake Disruption
Score: 0.44
Membrane Cholesterol Gradient Modulators
Score: 0.52
Microglia-Derived Extracellular Vesicle Engineering for Targ
Score: 0.37
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Vagal Afferent Microbial Signal Modulation
Score: 0.52
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
Vocal Cord Neuroplasticity Stimulation
Score: 0.50
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.69
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate
Score: 0.61
Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53
APOE4-Specific Microglial Metabolic Rescue
Score: 0.50
Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.55
Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53
Dual-Circuit Tau Vulnerability Cascade
Score: 0.50
Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio
Score: 0.49
Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62
Blood-Brain Barrier SPM Shuttle System
Score: 0.55
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Magnetosonic-Triggered Transferrin Receptor Clustering
Score: 0.47
Sphingolipid Metabolism Reprogramming
Score: 0.44
APOE Isoform Conversion Therapy
Score: 0.44
Show 25 more
Related Analyses (15)
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
Show 10 more
Related Experiments (23)
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.46
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.46
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.46
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.46
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.46
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.46
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.46
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.46
Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.46
Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.46
Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90
Multi-omics analysis of myricanol effects on gene expression
exploratory · proposed · Score: 0.88
Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.46
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.46
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.46
Anti-Tau Immunotherapy Dosing Optimization
clinical · proposed · Score: 0.46
tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.46
Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.46
Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.46
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.46
Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo
clinical · proposed · Score: 0.46
Tau Propagation Causality Test — Does Tau Spread Drive Neuro
clinical · proposed · Score: 0.46
Show 18 more
See Also (1)
Extracellular Vesicle and Tunneling Nanotube-Mediated S
mechanism · Pages share 3 hypotheses